Evoke Pharma Engages in Nationwide Gastroenterology Conference
![Evoke Pharma Engages in Nationwide Gastroenterology Conference](https://investorshangout.com/images/blog/ihnews-Evoke%20Pharma%20Engages%20in%20Nationwide%20Gastroenterology%20Conference.jpg)
Evoke Pharma Engages in Nationwide Gastroenterology Conference
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company dedicated to developing treatments for gastrointestinal (GI) diseases, has announced its participation in the Gastroenterology and Hepatology Advanced Practice Providers Conference. This significant event is set to take place over the course of three days at the Gaylord National Resort in National Harbor.
Matt D’Onofrio, the CEO of Evoke Pharma, expressed excitement about the company's continuous sponsorship of this pivotal conference, which focuses on nurse practitioners and physician assistants who significantly impact the management of patients struggling with GI disorders. D’Onofrio noted, "This gathering not only allows us to connect with advanced practice providers but also enables meaningful discussions regarding GIMOTI and its role in improving the lives of patients with diabetic gastroparesis. We are eager to engage with this community and share insights on our specialized treatment approaches."
At the conference, Evoke Pharma's management team, along with its commercial representatives, will host a booth aimed at fostering interactions and discussions with attendees. This immersive engagement will help healthcare providers understand the innovative solutions Evoke offers.
Understanding Gastroparesis and the Role of GIMOTI
Demittre Sorenson, a physician assistant at the Center for Advanced GI, emphasized the importance of GIMOTI in managing gastroparesis. Sorenson shared, "Through my extensive experience with GI patients, I often witness the struggles of those afflicted by gastroparesis. GIMOTI's nasal delivery system presents a promising alternative that can yield better outcomes compared to traditional oral medications. It provides much-needed relief, especially when symptoms are heightened, as it does not depend on the stomach's ability to process medication effectively."
This assertion signifies the potential of GIMOTI to significantly enhance the quality of life for patients dealing with this challenging condition, which affects millions globally.
About the Gastroenterology and Hepatology Advanced Practice Providers
The GHAPP organization is committed to advancing the professional development and education of advanced practice providers dedicated to the management of GI disorders. This annual conference represents an essential forum for healthcare professionals, focusing on the unique needs and challenges they face in their practice.
As the only national conference tailored specifically for APs in gastroenterology, it facilitates a deeper understanding of innovative treatments and the opportunity to share best practices among peers.
Innovative Treatments at the Forefront
Evoke Pharma has carved a niche in the pharmaceutical landscape through its focus on developing specialized medications for GI disorders. Among their key products is GIMOTI, which is specifically formulated to treat diabetic gastroparesis in adults. This condition inhibits the stomach from emptying its contents effectively, leading to various severe complications.
Before the introduction of GIMOTI to market, metoclopramide was only available as an oral or injectable drug, limiting options for patients. Now, GIMOTI provides an essential alternative, being the only FDA-approved treatment for gastroparesis currently available in the United States.
Learn More About Evoke Pharma
Individuals seeking more information on Evoke Pharma's innovative offerings and updates can visit their official website. The commitment to advancing GI treatment remains a cornerstone of the company’s mission, as they strive to meet the growing needs of patients and healthcare providers alike.
Frequently Asked Questions
What is Evoke Pharma focusing on during the GHAPP conference?
Evoke Pharma is focused on engaging healthcare providers and discussing their innovative treatment GIMOTI, particularly its effectiveness for diabetic gastroparesis.
What is GIMOTI?
GIMOTI is a nasal spray formulation of metoclopramide designed to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
What is the role of the GHAPP organization?
The GHAPP organization aims to provide education, resources, and professional advancement opportunities for advanced practice providers specializing in gastroenterology.
Why is the GHAPP conference important for advanced practice providers?
The conference is specifically designed to address the educational needs of providers who deal with GI disorders, offering them insights and peer discussions on best practices.
How can patients benefit from GIMOTI?
Patients benefit from GIMOTI as it offers an effective treatment option that does not rely on the stomach's ability to absorb medications, significantly improving their treatment experience.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Key Insights from Recent Stock Movements in Israel's Market
- Oslo OBX Index Sees Gains as Key Sectors Shine Bright
- Hermès Stock: Insights on Morgan Stanley's Revised Forecasts
- Moroccan Stock Market Sees Growth with All Shares Rising 0.51%
- The Case for Embracing the Equal-Weighted S&P 500 Index
- Citigroup's CFO Predicts Significant Uptick in Banking Fees
- Chopped Leaf Unveils the Irresistible Goddess Bowl Again
- Projected Growth of the Global Protective Packaging Market
- Analyzing Super Micro Computer's Challenges and Opportunities
- The MRI Market's Future: Growth and Innovations Ahead
Recent Articles
- Journey Medical's Upcoming Presence at Key Industry Conference
- Mama’s Creations Welcomes Supply Chain Expert Skip Tappan
- Banzai Welcomes Kent Schofield to Board, Boosting Leadership
- Consolidated Water Co. Ltd. Insights from the Virtual Conference
- Stereotaxis' Upcoming Investor Conference Participation Details
- Amendment Announcement for WisdomTree Natural Gas Securities
- WisdomTree Announces Results Following Securityholder Meeting
- Janus Henderson Foundation Celebrates 30 Years of Philanthropy
- Everlaw Expands Leadership with Gloria Lee as Chief Legal Officer
- Robert Forsyth's Exciting Role at Lazard Asset Management's ETF Team
- Starboard Value Advocates for Change at News Corp Shareholders
- BlackSky Technology Selected by NASA for Earth Imaging Support
- Customers Bank Expands Leadership Team for Future Success
- Volato Group Secures Compliance with NYSE American Standards
- First Eagle Investments Welcomes Michael Constantino as CFO
- ClearBridge Energy Midstream Fund Merger Enhances Investment Options
- Rexford Industrial Celebrates New Leasing Achievement in Realty
- Walgreens Faces Class Action: Understanding Your Rights as an Investor
- S2 Capital Expands Portfolio with Dartmouth Woods Acquisition
- Hall of Fame Resort: Upcoming Conferences and Insights
- Summit Therapeutics' Ivonescimab Shows Promise Against Keytruda
- CLPS Incorporation Successfully Meets Nasdaq Compliance Standards
- Moleculin Biotech Initiates Patient Treatments for Glioblastoma
- Borealis Foods CEO to Showcase Innovative Solutions at Conference
- Investors Gain Insight into MacroGenics, Inc. Legal Action
- Atomic Partners with Uphold to Transform Crypto Earnings
- Consumer Sentiment Shifts as Homebuying Dilemmas Persist
- Revolutionary Baby Wellness Device 'Elora' Launches in USA
- Kintara Therapeutics Invites Stockholder Participation in Merger
- AllRize Launches Innovative Platform for Legal Practice Management
- Avalara Appoints Kevin Sellers as New Chief Marketing Officer
- Michael Lollo Joins Mobile Network 24 as Chief Strategy Officer
- Lightwave Logic Welcomes Thomas Connelly, Jr. to Its Board
- New Executive Chef at The Abbey Resort Elevates Culinary Artistry
- Sembix Unveils Cost-Effective Solutions to Transform Systems
- Empowering Future Nurses: Bio-Oil's Inspiring Initiative
- Rehabtronics Teams Up with PressureSmart for Injury Prevention
- WSANDN: Pioneering Global Peace Initiatives for All Nations
- RAAPID INC's HITRUST Certification Ensures Secure Data Handling
- RBC Adjusts Kering Outlook Amidst Luxury Market Challenges
- Progress Software Set to Acquire ShareFile for Real Growth
- Jefferies Predicts Modest Expectations for iPhone 16 Sales
- Big Lots Secure Funding Amid Chapter 11 Bankruptcy Proceedings
- Investing in Energy Stocks: Opportunities in Exxon and More
- Exploring the Growth of Artificial Intelligence in Animation
- OSB Group PLC Reports Significant Managerial Transactions
- PickleJar Welcomes Industry Leaders to Advisory Board to Innovate
- Peter Schiff Highlights Risks in Tech Stocks and Cryptocurrencies
- Sage Potash Corp Enhances Operations with New Equipment Deal
- Decibel Cannabis Company Reveals Dried Flower Strategy Success